Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University Hospital, Ghent |
---|---|
Information provided by: | University Hospital, Ghent |
ClinicalTrials.gov Identifier: | NCT00389753 |
Comparison between use of Aruba Aloë formula F-BC-096 and control.
Condition | Intervention |
---|---|
Hydration of Scars |
Drug: Application of Aruba Aloë formula F-BC-096 or control |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Single Group Assignment, Efficacy Study |
Official Title: | A Prospective, Randomized, Double Blinded Controlled Clinical Trial of the Aruba Aloë Formula F-BC-096 in the Treatment of Split Thickness Donor Sites After Wound Closure |
Estimated Enrollment: | 25 |
Patients with two equal donor sites will be selected for inclusion. After wound healing one donor site will be treated with Aruba Aloë Formula F-BC-096 while a control product will be applied to the second site.
If pressure garments are applied they must be equal for both donor sites. During follow-ups objective methods will be used to evaluate elasticity and colour of the scar.
Ages Eligible for Study: | 3 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Henk Hoeksema, Research co-ordinator | 0032/(0)9/240.54.42 | henk.hoeksema@UGent.be |
Belgium | |
University Hospital Ghent | |
Ghent, Belgium, 9000 |
Principal Investigator: | Stan Monstrey, MD, PhD | University Hospital, Ghent |
Study ID Numbers: | 2006/326 |
Study First Received: | October 18, 2006 |
Last Updated: | December 19, 2007 |
ClinicalTrials.gov Identifier: | NCT00389753 |
Health Authority: | Belgium: Institutional Review Board |
Scars Hydratation After Treatment |
Cicatrix |